
The Pennsylvania attorney general has dropped his opposition to Jefferson Health’s acquisition of Einstein Healthcare Network, according to The Philadelphia Inquirer.
The decision to drop his challenge comes after the Federal Trade Commission lost its latest attempt to prevent the merger and Jefferson agreed to invest $200 million into Einstein’s Philadelphia hospitals.
“Following extensive talks with Jefferson and Einstein, the systems have committed to making investments in North Philadelphia that will go beyond what was initially proposed and are especially crucial while we face this global health pandemic,” the attorney general’s office told the Inquirer.
The FTC and the Pennsylvania attorney general’s office sued last February to block the transaction. They argued the combination of the two systems, which comprise 17 hospitals, would reduce competition in Philadelphia and Montgomery counties, resulting in price increases.
The US District Court for the Eastern District of Pennsylvania rejected the FTC and attorney general’s argument Dec. 8. The next day the FTC filed a motion for an emergency injunction pending an appeal, arguing the health systems will not be injured by temporarily delaying the transaction during the legal process. On Dec. 21, a panel of three judges from the 3rd Circuit Court of Appeals denied the FTC’s request to stay the merger.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Passes ‘Take It Down Act,’ the First Major AI-Related Federal Regulation
Apr 29, 2025 by
CPI
Michigan Sues Express Scripts, Prime Therapeutics for Alleged Price-Fixing Scheme
Apr 29, 2025 by
CPI
Tech Rivals Testify as FTC Antitrust Trial Against Meta Enters Defining Phase
Apr 29, 2025 by
CPI
Spanish Judge Investigates Nationwide Blackout as Possible Cyber Threat
Apr 29, 2025 by
CPI
Trump Administration Pushes EU to Delay AI Regulations
Apr 29, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Mergers in Digital Markets
Apr 21, 2025 by
CPI
Catching a Killer? Six “Genetic Markers” to Assess Nascent Competitor Acquisitions
Apr 21, 2025 by
John Taladay & Christine Ryu-Naya
Digital Decoded: Is There More Scope for Digital Mergers In 2025?
Apr 21, 2025 by
Colin Raftery, Michele Davis, Sarah Jensen & Martin Dickson
AI In the Mix – An Ever-Evolving Approach to Jurisdiction Over Digital Mergers in Europe
Apr 21, 2025 by
Ingrid Vandenborre & Ketevan Zukakishvili
Antitrust Enforcement Errors Due to a Failure to Understand Organizational Capabilities and Dynamic Competition
Apr 21, 2025 by
Magdalena Kuyterink & David J. Teece